Loading data...
TANSAQ Corporation
Representative Director
Mori Nishiwa
Creating the future of health through the power of 'Pre-symptomatic' care and data.
Recent News & PR
Summary
Message to Participants
Detailed Information
TANSAQ Corporation visualizes health risks through pre-disease testing and data analysis, supporting health management for individuals and companies. We provide innovative solutions based on scientific evidence to support future health development.
Unfair Advantage & Strengths
N/A
Competitors
N/A
Company Profile
事業カテゴリ
Healthcare / Biotech, AI / Data Analytics, DeepTech
本社所在地
Chuo-ku, Fukuoka, Japan
設立日
2022/04/07
資本金
null
Employee Count
1
Industry Outlook & Trends for TANSAQ Corporation
Driven by aging populations and rising healthcare costs, the healthcare and biotech market where TANSAQ Corporation operates is growing globally. Telemedicine, digital health via wearables, AI-driven drug discovery, and gene therapy are advancing rapidly. The industry is shifting from treatment to prevention, increasing demand for highly personalized health solutions like those developed by TANSAQ Corporation.
🔒
VPO Investor Pro Features
You are viewing a basic startup profile. Create a free account to access the dashboard. You can also upgrade to the "Investor Pro" plan to unlock full access to the following premium databases and features:
🎬
Elevator & Full Pitch Video
Watch full presentations with English/Japanese subtitles.
📊
AI Quick Report & Valuation
Get AI-driven assessment scores on market, product, and traction.
📅
Priority Challenges & Hiring
Access core corporate bottlenecks and current hiring plans.
📝
Full Transcripts
Read full pitch dialogue in both English and Japanese.
📈
Financials & Exit Strategy
Unlock IPO/M&A timelines and debt/equity plans.
👥
Advisors & Key Members
View internal team details and advisory board configurations.